FIELD: medicine. SUBSTANCE: method involves applying two-stage treatment as pulse therapy with 3 days long pause. Immunomodulation agent Leukinferon is administered as suppositories at a dose of 40000 active units daily, with 10 suppositories prescribed for the whole course. Treatment with Unidox and red laser radiation using semiconductor laser having 40-60% efficiency coefficient and 30 mW power. Rulid and transurethral laser stimulation are administered at the second treatment stage. EFFECT: enhanced effectiveness of treatment.
